Iron, magnesium, selenium, zinc, iodine, calcium, copper: read more about the functions and benefits of all the main minerals found […]
Collaboration of PharmaNutra and Parma Calcio has been reconfirmed: the Cetilar® brand will be on the team shirts for the […]
Construction work on PharmaNutra’s new pharmaceutical facility, assigned to the Venice-based general contractor SACAIM S.p.A. (Eccher Group), will commence in […]
Vitamins and minerals are essential elements in our diet, and along with carbohydrates, proteins and fats help our body to […]
A new clinical trial entitled “Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients […]
Today PharmaNutra has officially announced their renewed partnership with Pisa Sporting Club, the soccer team managed by Giuseppe Corrado that will […]
Over 180 international investors and 140 companies attended the event, in which Pharmanutra presented brilliant 2021 Q1 financial results to […]
PharmaNutra S.p.A. communicates the publication of a new, important scientific study on the use of ApportAL® for the treatment of […]
Motorsport team Cetilar Racing, supported by PharmaNutra, presents the new endurance racing season with the new #47 Ferrari 488 GTE […]
The 2021 STAR Conference organised by Borsa Italiana is an opportunity to meet MTA investors following publication of the 2020 […]
The “Marketing Project Work” education plan, which challenged Pisa University students for the launch of a new PharmaNutra product, recently […]
Sorry, this entry is only available in Italiano. Il via la prossima settimana a “PharmaNutra Sport Attitude”, una serie di […]
Sorry, this entry is only available in Italiano. PharmaNutra al fianco di SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) […]
2020 ended positively for Sucrosomial® iron-based products, which thanks to SiderAL® Forte have confirmed their market position. December’s market data*, […]
On 5ᵗʰ February, Midcap produced the “Small Touch” survey highlighting how PharmaNutra is performing more consistently that its peers. As […]
The third edition of the Italian Mid Cap Conference, organised by Mediobanca officially opened yesterday, seeing the participation of top […]
Le principali cause della stanchezza cronica e dei dolori muscolari diffusi.
The Higher Institute for Health (ISS) has classified Cetilar® Patch and Cetilar® Tape as Class 2A Medical Devices, while the U.S. […]
This morning saw the floating of shares in PharmaNutra S.p.A. on the MTA market – STAR segment of the Borsa […]
PharmaNutra and Zambon extend their collaboration to introduce two new Sucrosomial® Iron-based products to the Brazilian market. After the […]
The PharmaNutra Group will be present in Greece and Cyprus with its Cetilar® products, while SiderAL® Forte will be distributed […]
